A Phase II Study of Clofarabine in Patients With Relapsed or Refractory Multiple Myeloma
NCT00241371
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
8
Enrollment
OTHER
Sponsor class
Stopped
No response seen in patients
Conditions
Multiple Myeloma
Interventions
DRUG:
Clofarabine
Sponsor
Washington University School of Medicine